KIAA0196 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.941000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.016800E-01
Normal-vs-Stage2
9.832000E-01
Normal-vs-Stage3
1.073750E-01
Normal-vs-Stage4
5.728200E-01
Stage1-vs-Stage2
7.977000E-01
Stage1-vs-Stage3
1.391610E-01
Stage1-vs-Stage4
3.668800E-01
Stage2-vs-Stage3
2.043600E-01
Stage2-vs-Stage4
5.538800E-01
Stage3-vs-Stage4
8.667800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.955600E-01
Normal-vs-AfricanAmerican
7.534400E-01
Normal-vs-Asian
5.668200E-01
Caucasian-vs-AfricanAmerican
7.135800E-01
Caucasian-vs-Asian
3.802800E-01
AfricanAmerican-vs-Asian
7.537000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.681000E-01
Normal-vs-Female
8.896000E-01
Male-vs-Female
2.611800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.810000E-01
Normal-vs-Age(41-60Yrs)
6.773000E-01
Normal-vs-Age(61-80Yrs)
7.310400E-01
Normal-vs-Age(81-100Yrs)
8.721600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.346800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.313000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.420200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.269580E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.934000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.812400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.826600E-01
Normal-vs-Daily Drinker
7.169800E-01
Normal-vs-Weekly Drinker
6.795000E-01
Normal-vs-Occasional Drinker
5.189600E-01
Normal-vs-Social Drinker
9.951000E-01
Non Drinker-vs-Daily Drinker
7.337400E-01
Non Drinker-vs-Weekly Drinker
7.939800E-01
Non Drinker-vs-Occasional Drinker
7.280400E-02
Non Drinker-vs-Social Drinker
7.551800E-01
Daily Drinker-vs-Weekly Drinker
9.625600E-01
Daily Drinker-vs-Occasional Drinker
6.476400E-02
Daily Drinker-vs-Social Drinker
4.840600E-01
Weekly Drinker-vs-Occasional Drinker
6.920200E-02
Weekly Drinker-vs-Social Drinker
4.990000E-01
Occasional Drinker-vs-Social Drinker
1.535600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.781600E-01
Normal-vs-Grade 2
2.572800E-01
Normal-vs-Grade 3
1.472820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.648250E-01
Grade 1-vs-Grade 3
9.262500E-03
Grade 1-vs-Grade 4
3.781600E-01
Grade 2-vs-Grade 3
7.852000E-02
Grade 2-vs-Grade 4
2.572800E-01
Grade 3-vs-Grade 4
1.472820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.828600E-01
Normal-vs-NonDiabetic
8.097200E-01
Diabetic-vs-NonDiabetic
3.363400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.645000E-01
Normal-vs-NoPancreatitis
9.216200E-01
Pancreatitis-vs-NoPancreatitis
6.285200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.893600E-01
Normal-vs-N1
9.566000E-01
N0-vs-N1
5.082200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.699600E-01
Normal-vs-TP53-NonMutant
7.253200E-01
TP53-Mutant-vs-TP53-NonMutant
2.337400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
